Ribosomal Translation

RiPPs (Ribosomally Synthesized and Post-Translationally Modified Peptides)

Summary

Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs) are a diverse class of bioactive natural products that originate from gene-encoded precursor peptides. Their biosynthesis relies on a leader peptide sequence that recruits specific enzymes to modify a core peptide segment.

Key Points

  • 1RiPPs are gene-encoded peptides modified by post-translational enzymes
  • 2Leader peptides recruit modification enzymes while core peptides become the final product
  • 3Modifications include lanthionine bridges, thiazole rings, macrolactams, and lasso topologies
  • 4Lantibiotics like nisin use thioether crosslinks for antimicrobial activity
  • 5RiPP biosynthesis combines ribosomal efficiency with non-ribosomal chemical diversity

RiPPs represent a hybrid biosynthetic strategy that combines the efficiency of ribosomal synthesis with the chemical diversity typically associated with non-ribosomal pathways.

Precursor Peptide Architecture

Two-Part Structure

RiPP precursor peptides consist of:

1. Leader peptide: An N-terminal sequence that recruits modification enzymes but is cleaved in the final product

2. Core peptide: The C-terminal segment that becomes the mature, bioactive product

The leader peptide acts as a recognition element, binding to modification enzymes and positioning the core peptide for catalysis.

Modification Diversity

Post-translational modifications convert simple amino acid sequences into complex, chemically diverse structures:

- Lanthionine bridges: Thioether crosslinks formed in lantibiotics (e.g., nisin)

- Thiazole/oxazole rings: Heterocycles formed from Cys, Ser, or Thr

- Macrolactams: Large ring structures from head-to-tail or side-chain cyclization

- Lasso topologies: Threaded ring-and-tail architectures resistant to proteolysis

Major RiPP Classes

Lantibiotics

Characterized by lanthionine and methyllanthionine thioether bridges. Nisin, the prototypical lantibiotic, is widely used as a food preservative due to its antimicrobial activity against Gram-positive bacteria.

Thiopeptides

Contain thiazole rings and a characteristic six-membered nitrogen heterocycle. Examples include thiostrepton, which inhibits ribosomal translation.

Lasso Peptides

Feature a unique rotaxane-like topology where the C-terminal tail threads through an N-terminal macrolactam ring. This structure confers exceptional stability against proteases and thermal denaturation.

Cyanobactins

Cyclic peptides from cyanobacteria, often containing heterocyclic modifications. Patellamides are examples with metal-binding properties.

Biosynthetic Advantages

Evolvability

Because RiPPs are gene-encoded:

  • Point mutations can rapidly alter the core peptide sequence
  • Libraries of variants can be generated through directed evolution
  • The leader peptide ensures enzyme recognition is maintained
  • Engineering Potential

    RiPPs offer unique opportunities for drug discovery:

    - Low metabolic cost: Ribosomal synthesis is energetically efficient

    - High diversity: PTM enzymes generate chemical complexity

    - Modularity: Leader peptides can be swapped to create chimeric pathways

    Therapeutic Applications

    RiPPs are sources of:

  • Antibiotics (nisin, thiostrepton)
  • Antitumor agents
  • Enzyme inhibitors
  • Bioactive scaffolds for drug development